LL-37
$350.00
$350
5 mL vial, 2 mg per mL
Recommended Protocol
• 4–8 weeks continuous use
• Followed by reassessment before continuation.
One vial typically lasts approximately 30 days, depending on individualized dosing protocol.
Duration and dosing structure should be determined under provider guidance.
Unlike traditional immune “boosters,” LL-37 does not simply stimulate immune activity. Instead, it participates in coordinated immune communication pathways that regulate defense, repair, and inflammatory response.
This makes LL-37 a structured immune-modulation peptide rather than a general immune stimulant.
Key Benefits
- Supports innate immune defense signaling
- Assists in inflammatory balance
- Supports epithelial and tissue integrity
- May enhance cellular resilience under stress
- Designed for structured short-term immune optimization
Learn how to administer safely in seconds.
Intramuscular Injections
Subcutaneous Injections
WHO MAY BENEFIT
LL-37 may be considered in structured protocols for individuals who:
- Experience recurrent immune stress
- Are undergoing intense physical training blocks
- Are exposed to high environmental stress loads
- Are implementing regenerative or recovery protocols
- Seek short-term immune system modulation under provider supervision
It is often used as part of a targeted immune block rather than a continuous daily compound.
⸻
MECHANISM OF ACTION
LL-37 interacts with:
- Macrophages
- Neutrophils
- Epithelial tissue
- Cytokine signaling pathways
It has been studied in research settings for its involvement in:
- Host defense peptide signaling
- Antimicrobial pathway activity
- Inflammatory modulation
- Biofilm research contexts
- Tissue repair signaling pathways
Rather than indiscriminately increasing immune stimulation, LL-37 supports immune communication and response coordination.
⸻
IMMUNE & PERFORMANCE POSITIONING
High-performance individuals often operate under sustained physiological stress — whether from:
- Travel
- Intense training
- High workload
- Environmental exposure
Structured immune support blocks using peptides like LL-37 may be incorporated to support resilience during these periods.
It is not typically positioned for indefinite year-round use, but rather short, goal-oriented cycles.